BioCryst Pharmaceuticals Inc

BioCryst Pharmaceuticals Inc

Health CarePharmaceuticals & Biotechnology
  • Price (USD)4.58
  • Today's Change0.08 / 1.78%
  • Shares traded911.89k
  • 1 Year change-48.31%
  • Beta3.7392
Data delayed at least 15 minutes, as of Oct 26 2016 21:00 BST.
More ▼

Events & Activity

  • BCRX:NSQ price moved over +1.11% to 4.56
  • BCRX:NSQ trading volume exceeds daily average by +15.26%
  • BCRX:NSQ price falls below 50-day moving average to 4.39 at 14:20 BST

Key statistics

On Wednesday, BioCryst Pharmaceuticals Inc (BCRX:NSQ) closed at 4.58, 180.98% above the 52 week low of 1.63 set on Feb 12, 2016.
52-week range
1.63Feb 12 201610.98Dec 30 2015
Markit short selling activity
Previous close4.50
Average volume528.75k
Shares outstanding73.70m
Free float72.65m
P/E (TTM)--
Market cap340.50m USD
EPS (TTM)-0.978 USD
Data delayed at least 15 minutes, as of Oct 26 2016 21:00 BST.
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.